These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1279306)

  • 1. How to evaluate class III antiarrhythmic drug efficacy clinically: the benefits and shortcomings of the noninvasive approach.
    Andresen D; Behrens S; Stern R; Brüggemann T; Schröder R
    J Cardiovasc Pharmacol; 1992; 20 Suppl 2():S28-31. PubMed ID: 1279306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of Holter electrocardiogram in the evaluation of anti-arrhythmia therapy].
    Meoli P; Sanna G
    G Ital Cardiol; 1987 Dec; 17(12):1114-20. PubMed ID: 3332646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Value of Holter's dynamic ECG a as predictor of the effectiveness of anti-arrhythmia therapy].
    Sanna GP
    G Ital Cardiol; 1986 Aug; 16(8):663-6. PubMed ID: 3792732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy with and assessment of class III antiarrhythmic agents in different patient populations.
    Podrid PJ
    J Cardiovasc Pharmacol; 1992; 20 Suppl 2():S44-58. PubMed ID: 1279309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to evaluate class III antiarrhythmic drug efficacy clinically: the benefits and shortcomings of the invasive approach.
    Borggrefe M; Haverkamp W; Shenasa M; Hindricks G; Breithardt G
    J Cardiovasc Pharmacol; 1992; 20 Suppl 2():S32-40. PubMed ID: 1279307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of Holter monitoring and electrophysiological studies in the evaluation of ventricular anti-arrhythmia agents].
    Frank R; Raguin D; Tonet J; Fontaine G
    Arch Mal Coeur Vaiss; 1991 Feb; 84 Spec No 2():21-5. PubMed ID: 1726995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation and treatment of ventricular arrhythmias: an update.
    McCollam PL; Parker RB
    Clin Pharm; 1991 Mar; 10(3):195-205. PubMed ID: 2040126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of ambulatory ECG in a cardiology department].
    Pesola A; Magini G
    G Ital Cardiol; 1987 Dec; 17(12):1055-62. PubMed ID: 3503801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ventricular tachyarrhythmia. Drug therapy and evaluation of success].
    Seipel L; Kühlkamp V
    Z Kardiol; 1993; 82 Suppl 5():155-61. PubMed ID: 8154157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Propafenone and flecainide in the therapy of ventricular arrhythmias].
    Paperini L; Davini A; Lattanzi F; Topi A; Reisenhofer B; Squarcini G; Paci A; Topi PL
    Minerva Cardioangiol; 1995 Oct; 43(10):449-57. PubMed ID: 8819814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term antiarrhythmic pharmaco-therapy guided by Holter monitoring in patients with malignant ventricular arrhythmias and ischemic heart disease.
    Trusz-Gluza M; Gasior Z; Wnuk-Wojnar AM; Filipecki A; Szydło K; Giec L
    Mater Med Pol; 1992; 24(4):229-32. PubMed ID: 1308049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
    Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
    G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Methods of antiarrhythmic drug evaluation in man].
    Libersa C; Caron J; Guedon-Moreau L; Tricot O; Bordet R
    Therapie; 1994; 49(3):201-9. PubMed ID: 7878585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive diagnosis of ventricular arrhythmias by means of ambulatory-ECG monitoring.
    Candinas RA; Podrid PJ
    Herz; 1990 Feb; 15(1):1-10. PubMed ID: 2179087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Control of the efficacy of anti-arrhythmic treatments].
    Coumel P
    Schweiz Med Wochenschr; 1981 Nov; 111(45):1688-91. PubMed ID: 7313633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term variability in unsustained ventricular arrhythmias: pharmacologic and pro-arrhythmic effect].
    Gaita F; Richiardi E; Bobbio M; Chiotti D; Brusca A
    G Ital Cardiol; 1989 Oct; 19(10):908-12. PubMed ID: 2482213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Usefulness of an electrophysiological study in the management of patients with tachyarrhythmias].
    Sugimoto T
    J Cardiol; 1989 Mar; 19(1):317-21. PubMed ID: 2810048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Plasma levels of anti-arrhythmic drugs and clinical effectiveness in the treatment of ventricular arrhythmias].
    Bracchetti D; Naccarella F; Guaragna RF; Palmieri M; Bartoletti A; Barbato G; Malini PL; Marchesini B; Ambrosioni E
    G Ital Cardiol; 1986 Aug; 16(8):648-59. PubMed ID: 3539687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ventricular cardiac arrhythmias 1992. Summary and perspectives].
    Breithardt G; Borggrefe M
    Z Kardiol; 1992; 81 Suppl 4():163-5. PubMed ID: 1290293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Flecainide: a new antiarrhythmic agent].
    Leclercq JF; Coumel P
    Arch Mal Coeur Vaiss; 1983 Oct; 76(10):1218-30. PubMed ID: 6418100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.